Data reveals that up to 46.5% of NICU admissions involve a respiratory component,¹ with many infants requiring noninvasive or invasive mechanical ventilation due to immature respiratory systems. During ventilation, the goal is to ensure adequate gas exchange (oxygenation and CO2 removal), while also minimizing ventilator induced lung injury (VILI). Because these infants are extremely fragile, maintaining that delicate balance is both challenging and critical for achieving the best possible outcomes.

To optimize ventilation, it is essential to monitor key gas exchange targets closely. CO2 is a direct reflection of how well ventilation matches metabolic demand, making it one of the most important parameters guiding ventilator management. Continuous CO2 monitoring not only shows whether settings are supporting effective gas exchange and helps clinicians avoid the risks of too-high or too-low CO2, but it also signals when support may be too strong — preventing potential lung overdistention and injury.

CO2 monitoring can play an important role in guiding effective respiratory care in the NICU, but the method you choose matters. Each monitoring method offers different strengths and limitations, and understanding these can help care teams choose the approach that best supports their patients.

Arterial blood gas tests provide a direct measurement of PaCO2 using a blood sample, usually drawn from the radial or brachial artery.

The pros: 

• Considered the gold standard for accuracy
• Provides multiple parameters in a single measurement (pH, CO₂, O₂, HCO₃⁻, electrolytes)
• Direct assessment of arterial blood gas values

The limitations: 

• Invasive and carries the risk of infection
• Causes pain and stress for neonates, which has been shown to negatively affect short- and long-term outcomes
• Adds to overall blood loss, a meaningful risk for preterm babies with limited blood volume
• Only provides a point-in-time measurement, which can leave CO2 fluctuations to go undetected

In summary… 

Arterial blood sampling is, and will continue to be, a vital tool in neonatal care, providing accurate, direct measurements of key parameters. However, inherent limitations, including pain, blood loss, and infection risk, underscore the need to consider supplemental strategies. The absence of continuous data is also a concern in the NICU, where even small changes can significantly impact fragile patients, emphasizing the value of methods that instead provide continuous, real-time insights.

End-tidal CO2 (EtCO2) monitoring measures CO2 in exhaled air at the end of each breath, typically using a nasal or airway sensor.

The pros:

• Noninvasive
• Provides continuous, real-time CO2 measurements
• Effective at guiding endotracheal tube placement
• Provides a waveform that clinicians can use to interpret compliance and resistance
  issues

The limitations:

• Accuracy can be affected by leakage around uncuffed endotracheal tubes
• Ineffective with small tidal volumes and higher respiratory rates/short exhalation time
• Can be inaccurate in patients with ventilation-perfusion (V/Q) mismatch
• Incompatible with noninvasive ventilation (NIV) modalities like NPPV, HFNC, NIV-NAVA, and bubble CPAP
• Adds dead space to the circuit and weight to the ET tube

In summary…
Capnography can be a valuable tool, as it provides continuous insight that ABGs cannot, offers waveform data, and can guide ET tube placement during intubations. However, its usefulness is limited in many NICU patients, such as those with V/Q mismatch, small tidal volumes, or those receiving noninvasive ventilation. These limitations make it challenging to rely on capnography as a consistent CO2 monitoring tool in a NICU.

Transcutaneous CO2 monitoring is a continuous, noninvasive method where a sensor is placed on the neonate’s skin and gently heated. This heating enhances local perfusion, allowing CO2 from the blood to diffuse through the skin into the sensor, which then accurately estimates arterial CO2 levels.

The pros:

• Noninvasive
• Provides continuous, real-time CO2 measurements
• Maintains accuracy even with low tidal volumes, high respiratory rates, and V/Q mismatch
• Compatible with noninvasive and high-frequency ventilation
• Suitable for very low birth weight infants

The limitations:

• Sensor requires regular calibration
• Poor perfusion at the measurement site can affect accuracy
• Does not provide a breath-to-breath waveform

In summary…
Transcutaneous CO2 monitoring offers continuous, noninvasive insight into an infant’s ventilation, avoiding the discomfort and single-point limitations of arterial blood gases. Compared with end-tidal monitoring, it remains accurate even in the presence of ventilation-perfusion mismatch, small tidal volumes, or noninvasive ventilation, making it a more reliable option for many NICU patients. While it does require regular calibration, can be affected by poor perfusion, and does not provide a breath-to-breath waveform, its applicability across a wide range of NICU patients makes it a valuable tool. By tracking CO2 trends in real time, care teams can detect fluctuations early, adjust ventilatory support appropriately, and help protect the developing brains and lungs of fragile preterm infants.